Evidence map›Paper›PMID 34740473›Full record

ArticleVaccine2021

COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.

Helena C Maltezou, Periklis Panagopoulos, Flora Sourri, Theodoros V Giannouchos, Vasilios Raftopoulos, Maria N Gamaletsou, Amalia Karapanou, Dimitra-Maria Koukou, Athanasia Koutsidou, Emmanuela Peskelidou and 5 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. First Responders Have Lower COVID-19 Vaccination Rates Than Other Healthcare Providers.Journal of the American College of Emergency Physicians open · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Consequences of COVID-19 Vaccine Hesitancy Among Healthcare Providers During the First 10 Months of Vaccine Availability: Scoping Review.The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 2 countries.

Helena C MaltezouDirectorate of Research, Studies and Documentation, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.
Periklis PanagopoulosSecond Department of Internal Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Flora SourriDepartment of Infection Control, 251 Hellenic Air Force General Hospital, Athens, Greece.
Theodoros V GiannouchosDepartment of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States.
Vasilios RaftopoulosDepartment of HIV Surveillance, National Public Health Organization, Athens, Greece.
Maria N GamaletsouPathophysiology Department, Medical School, National and Kapodistrian University of Athens, Greece.
Amalia KarapanouInfection Control Committee, Laiko General Hospital, Athens, Greece.
Dimitra-Maria KoukouFirst Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.
Athanasia KoutsidouInfection Control Committee, Alexandroupolis University Hospital, Alexandroupolis, Greece.
Emmanuela PeskelidouCOVID-19 Intensive Care Unit, 424 General Military Hospital of Thessaloniki, Thessaloniki, Greece.
Konstantina PapanastasiouOperating Rooms, 424 General Military Hospital of Thessaloniki, Thessaloniki, Greece.
Kyriakos SouliotisFaculty of Social and Political Sciences, University of Peloponnese, Corinth, Greece; Health Policy Institute, Athens, Greece.
Athanasia LouridaInfection Control Committee, Aghia Sofia Children's Hospital, Athens, Greece.
Nikolaos V SipsasPathophysiology Department, Medical School, National and Kapodistrian University of Athens, Greece.
Dimitrios HatzigeorgiouMedical Directorate, Hellenic National Defence General Staff, Athens, Greece.
National and Kapodistrian University of Athens · GR424 General Military Hospital · GRHellenic Air Force · GRNational Public Health Organization · GRDemocritus University of Thrace · GRIaso Children’s Hospital · GRLaiko General Hospital of Athens · GRUniversity Hospital of Alexandroupolis · GRUniversity of Peloponnese · GRUniversity of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimHealthcare personnel (HCP) are prioritized for coronavirus disease 2019 (COVID-19) vaccination to protect them and non-disruptive provision of healthcare services. We assessed the impact of the Pfizer-BioNTech vaccine on morbidity and absenteeism among HCP.

methodsWe studied 7445 HCP in five tertiary-care hospitals in Greece from November 15, 2020 through April 18, 2021.

resultsA total of 910 episodes of absenteeism and 9695 days of absence were recorded during the entire study period. Starting from January 4, 2021, 4823/7445 HCP (64.8%) were fully or partially vaccinated. Overall, 535 episodes of absenteeism occurred from January 4, 2021 through April 18, 2021, including 309 (57.76%) episodes among 2622 unvaccinated HCP and 226 (42.24%) episodes among 4823 vaccinated HCP (11.8 versus 4.7 episodes of absenteeism per 100 HCP, respectively; p-value < 0.001). The mean duration of absenteeism was 11.9 days among unvaccinated HCP compared with 6.9 days among vaccinated HCP (p-value < 0.001). Unvaccinated HCP more frequently developed acute respiratory infection, influenza-like illness, and COVID-19 (p-values < 0.001 for all comparisons). Vaccine effectiveness for fully vaccinated HCP was estimated at 94.16% [confidence interval (CI): 88.50%-98.05%) against COVID-19, 83.62% (CI: 73.36%-90.38%) against SARS-CoV-2 infection (asymptomatic or COVID-19), and 66.42% (CI: 56.86%-74.15%) against absenteeism.

conclusionThe COVID-19 pandemic had a considerable impact on healthcare workforce. The Pfizer-BioNTech vaccine significantly reduced morbidity, COVID-19, absenteeism and duration of absenteeism among HCP during a period of high SARS-CoV-2 circulation in the community. It is expected that HCP vaccination will protect them and healthcare services and contain healthcare costs.

Indexed as

AbsenteeismCOVID-19COVID-19 VaccinesDelivery of Health CareHealth PersonnelHumansMorbidityPandemicsProspective StudiesSARS-CoV-2VaccinationCOVID-19 VaccinesAbsenteeismCOVID-19Healthcare personnelMorbidityVaccination

Identifiers

PMID34740473
PMCPMC8556541
OpenAlexW3208694994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.